Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-a in high-risk melanoma patients

AR Gool, H Ojik, Wim Kruit, PGH (Paul) Mulder, Durk Fekkes, M Bannink, S Scharpé, Gerrit Stoter, Lex Eggermont, M Maes, R Verkerk

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)411-415
Number of pages5
JournalJournal of Interferon and Cytokine Research
Publication statusPublished - 2004

Cite this